| Molecular formula | C45H55N9O6 |
|---|
| Molecular weight | 818 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 6918245 |
|---|
What GHRP-2 is
GHRP-2 is a synthetic peptide compound identified in chemical databases by PubChem CID 6918245. It has a molecular formula of C45H55N9O6 and a molecular weight of approximately 818 g/mol. GHRP-2 does not have an FDA-approved label, and no approved brand names, indications, or dosing information exist for it. It is classified as unapproved and is used only in a research context.
Trial footprint
Public clinical trial registries show no registered trials for GHRP-2 at this time. There is no sample of trial records to report on for this compound. This absence of registered trials means there is no clinical trial evidence base currently available to describe its study status.
FAQ
No, GHRP-2 does not have FDA approval and there is no FDA-approved drug label associated with it. It is classified as an unapproved research compound. No approved indications, brand names, or dosing guidance exist for it.
GHRP-2 is a synthetic peptide with the molecular formula C45H55N9O6 and a molecular weight of about 818 g/mol. It is catalogued in PubChem under CID 6918245.
Public registry data reviewed for this monograph show zero registered clinical trials for GHRP-2. This means there is currently no clinical trial record available to summarize for this compound.
No adverse event report data was available for GHRP-2 at the time this monograph was compiled. Because it lacks an approved label, there is no established side effect profile to reference.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-09-19